Program areas at Mary Bird Perkins Cancer Center
Patient care activities:mary Bird Perkins Cancer Center (mbpcc) is the leading Cancer care organization in Louisiana providing state-of-the-art radiation therapy treatment and comprehensive Cancer care to patients regardless of ability to pay. Mbpcc, through its seven locations, serves 18 parishes (counties) across southeast Louisiana and portions of southwest Mississippi, home to approximately 1.5 million people. During july 1, 2021 june 30, 2022, mbpcc provided approximately 44,398 radiation therapy treatments to 7,814 patients seeking Cancer care. During the same period, mbpcc provided continuing Cancer care through 5,618 follow-up patient visits following therapy completion. Patients receiving care during july 1, 2021 june 30, 2022 were provided access to national and local clinical research trials investigating ways to better prevent, detect, diagnose, and treat Cancer. Mbpcc is accredited by the american college of radiology and the american college of surgeons - two nationally recognized accrediting organizations. During july 1, 2021 june 30, 2022, approximately 29% of its gross patient revenue was derived from patient participation in either the medicare or medicaid program. Mbpcc is the sole provider of radiation therapy services to patients of lsu health care services and lallie kemp regional medical Center, both public hospitals serving the medically indigent population in southeast Louisiana. Costs incurred in july 1, 2021 june 30, 2022 to provide care in excess of reimbursement received from the medicare and medicaid programs, were $5,926,000. Mbpcc also provided $14,021 of discounts and waived collection efforts under its patient discount policy for those qualifying patients.
Medical physics residency program:mbpcc plays a significant role in the Mary Bird Perkins Cancer Center Louisiana state university (mbpcc-lsu) medical physics and health physics program. This academic program provides didactic instruction and clinical and research training to the lsu ms and phd graduate students in medical physics. Graduates of this program become medical physicists. The lsu medical physics academic program is one of the largest in the country training medical physicists to serve Cancer programs nationwide. Although much of the mbpcc medical physicists' budget supports its phd staff (lsu adjunct faculty) to perform translational medical physics research, it also includes teaching in the mbpcc - lsu medical physics program and mentoring of graduate student research. Graduate students work to complete over 20 research projects every year impacting Cancer treatment worldwide. In addition, mbpcc provides student classroom space, student offices, teaching labs, research labs, clinical training facilities, administrative support and supplies. Mbpcc has numerous research grants, which provide funding for its medical physicists, support staff, and postdoctoral fellows, as well as lsu graduate research assistants.
Cancer program activities:mbpcc believes communities benefit when the expertise of local hospitals, physicians, support organizations solely focused on Cancer are linked together to form a comprehensive Cancer program. Cancer patients benefit from the convenience of high-quality, advanced medical treatment and care in one location within their community at less cost to both organizations. To date, mbpcc has implemented three comprehensive Cancer program models and assumed certain responsibilities for developing and delivering the Cancer care continuum to the local community. Services include Cancer prevention education, early detection, free Cancer screening, and transportation assistance. As well as unique programs of public and professional education, clinical trials and Cancer research. During july 1, 2021 through june 30, 2022, the Cancer programs screened 5,426 people at 264 free Cancer screening events for breast, prostate, oral, colon and skin cancers. Since 2002, over 107,000 people throughout southeast Louisiana have been screened for Cancer at no cost to participants. July 1, 2021 through june 30, 2022, 662 (12%) of the screened participants were navigated due to abnormal findings and 37 were diagnosed with Cancer. For the uninsured, grants and donations provided funding for follow-up tests, such as colonoscopies and biopsies. Educational programs regarding Cancer were conducted for 7,518 people attending community events. Each Cancer program, including outreach, survivorship and clinical research, relies on grants and philanthropy to fund these services.